Type
1.
Rebollo M, Bockarie M. Can lymphatic filariasis be eliminated by 2020? Trends in parasitology. 2016;
Type
1.
Sodahlon Y, Malecela M, Gyapong J. Lymphatic filariasis (Elephantiasis). In: Neglected Tropical Diseases-Sub-Saharan Africa. Springer; 2016. pp. 159–186.
Type
1.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2014. Weekly epidemiological record [Internet]. 2015;90(38):489-504. Available from: http://www.who.int/wer/2015/wer9038.pdf?ua=1
Type
1.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2013. Weekly epidemiological record [Internet]. 2014;89(38):409-18. Available from: http://www.who.int/wer/2014/wer8938.pdf?ua=1
Type
1.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report for 2012. Weekly epidemiological record [Internet]. 2013;88(37):389-400. Available from: http://www.who.int/wer/2013/wer8837.pdf?ua=1
Type
1.
Njenga S, Mwandawiro C, Muniu E, Mwanje M, Haji F, Bockarie M. Adult population as potential reservoir of NTD infections in rural villages of Kwale district, Coastal Kenya: implications for preventive chemotherapy interventions policy. Parasites & vectors [Internet]. 2011;4:175. Available from: http://parasitesandvectors.biomedcentral.com/articles/10.1186/1756-3305-4-175
Type
1.
Krentel A, Damayanti R, Titaley CR, Suharno N, Bradley M, Lynam T, et al. Improving coverage and compliance in mass drug administration for the elimination of LF in two ‘endgame’ districts in Indonesia using micronarrative surveys. PLoS neglected tropical diseases [Internet]. 2016;10(11):e0005027. Available from: http://journals.plos.org/plosntds/article/asset?id=10.1371/journal.pntd.0005027.PDF
Type
1.
Narahari S, Manjula K, Bose K, Aggithaya MG, Swamy G, Ryan T. Harmful traditional healing practices in the treatment of lymphatic filariasis. Indian journal of dermatology, venereology and leprology [Internet]. 2016;82(5):565-7. Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=2016;volume=82;issue=5;spage=565;epage=567;aulast=Narahari
Type
1.
Turner H, Bettis A, Chu B, McFarland D, Hooper P, Mante S, et al. Investment success in public health: An analysis of the cost-effectiveness and cost-benefit of the Global Programme to Eliminate Lymphatic Filariasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016;
Type
1.
Mupfasoni D, Montresor A, Mikhailov A, King J. The impact of lymphatic filariasis mass drug administration scaling down on soil-transmitted helminth control in school-age children. Present situation and expected impact from 2016 to 2020. PLoS neglected tropical diseases [Internet]. 2016;10(12):e0005202. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005202&type=printable
Pagination
- Previous page
- Page 12
- Next page